Indivior PLC
LSE:INDV
Indivior PLC
Net Income (Common)
Indivior PLC
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Indivior PLC
LSE:INDV
|
Net Income (Common)
$5m
|
CAGR 3-Years
-63%
|
CAGR 5-Years
-54%
|
CAGR 10-Years
N/A
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Net Income (Common)
£4.5B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-1%
|
|
AstraZeneca PLC
LSE:AZN
|
Net Income (Common)
$6.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
21%
|
CAGR 10-Years
12%
|
|
Verona Pharma PLC
NASDAQ:VRNA
|
Net Income (Common)
-$54.4m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Net Income (Common)
$190m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-1%
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Net Income (Common)
-£27.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Indivior PLC's Net Income (Common)?
Net Income (Common)
5m
USD
Based on the financial report for Mar 31, 2024, Indivior PLC's Net Income (Common) amounts to 5m USD.
What is Indivior PLC's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-54%
The average annual Net Income (Common) growth rates for Indivior PLC have been -63% over the past three years , -54% over the past five years .